Skip to main content

Regulatory and Washington

  • CDC report: Some ethnic groups need to boost vitamin D, iron supplementation

    ATLANTA — Overall, the U.S. population has good levels of vitamin A and folate in the body, but some groups still need to increase their levels of vitamin D and iron, according to the "Second National Report on Biochemical Indicators of Diet and Nutrition," released Monday by the Centers for Disease Control and Prevention.

  • Super PBM merger approved; NACDS, NCPA file emergency motion to block merger

    WASHINGTON — The controversial merger between Express Scripts and Medco was completed Monday morning, according to a press release issued by both Express Scripts and the Federal Trade Commission.

  • FDA OKs Levemir for pregnant women

    NEW YORK — A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

    Novo Nordisk said Monday the FDA had approved Levemir (insulin detemir [rDNA origin]) for a pregnancy category B classification, meaning that when used by pregnant women, the insulin did not increase the risk of harm to fetuses. The agency's decision was based on results of a clinical trial involving 310 women that compared Levemir to another insulin product.

    The insulin is used to treat Type 1 and Type 2 diabetes.

  • NACDS, NCPA renew merger opposition with new court filing seeking immediate relief

    ALEXANDRIA, Va. — The National Association of Chain Drug Stores and the National Community Pharmacists Association on Monday afternoon announced their intent to file an additional motion requesting that the judge direct Express Scripts and Medco to keep separate their assets pending review of the lawsuit and/or schedule an expedited review of the merits of a case the two associations filed in district court last week.

  • NCPA submits comments to House committee debating H.R. 1946

    ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday submitted written comments to the U.S. House Judiciary Committee Subcommittee on Intellectual Property, Competition and the Internet hearing on H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act, in support of the bill.

  • GSK advocates broadening scope of nicotine replacement therapy

    PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare strongly supported efforts to inform smokers of the impact tobacco use has on the body, as well as effective ways to quit, during a congressional briefing Friday that was sponsored by Reps. Frank Pallone, D-N.J., and Tim Murphy, R-Pa.

    The briefing, entitled "Understanding Smoking Addiction and How to Accelerate Quitting," addressed how to improve the nation's policies and programs to help smokers become tobacco free.

  • Report: Cancer death rates continue to decline

    ATLANTA — Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

  • FTC testifies on anticompetition potential of an independent pharmacy bloc

    WASHINGTON — The House Judiciary Committee's Subcommittee on Intellectual Property, Competition and the Internet on Thursday morning heard testimony regarding H.R. 1946, "Preserving Our Hometown Independent Pharmacies Act of 2011." Originally introduced by Reps. Tom Marino, R-Pa., and Louie Gahmert, R-Texas, the bill is intended to exempt independent pharmacists from antitrust regulation in an effort to bolster their negotiating powers with pharmacy benefit managers.

X
This ad will auto-close in 10 seconds